The month in life sciences and intellectual property
In our most recent Synthesis issue, the month in life sciences and intellectual property news: Defining the limits of protection that skinny labels afford; the impact of FDA approval timelines on royalty payments; USPTO director’s decision highlights consequences of evidence suppression; and more.
Read more here.